Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on sensitive data.
The decision came to light after a official document from December was disclosed, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
A government representative later explained that the US was requesting genetic material for scientific study and profit but was not willing to guarantee the benefits from any future treatments.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for more dialogue to find a agreement suitable to both sides so the nation's critical HIV programme can continue.
Broader Implications
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court suspended a related deal with the US after legal challenges were raised about the security of Kenyans' health data.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
As per reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data indefinitely, without any corresponding promise of access to any medical innovations – like new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be available to our people if a new pandemic emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already established through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future collaboration might be designed in a way that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations should continue considering a large portion of the nation's HIV programmes depended on external financing.
"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group commented.
The situation highlights the complex debate between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.